Molecular breast imaging
This article was originally published in The Gray Sheet
Executive Summary
Procedure may be a useful adjunct to mammography screens in detecting breast cancer in women at risk for the disease or with dense breasts, according to a study presented at the American Society of Clinical Oncology's annual Breast Cancer Symposium Sept. 5-7 in Washington, D.C. A 15-month follow-up of 375 women in the 940-patient trial, conducted at the Mayo Clinic in Rochester, Minn., showed that MBI had 75% sensitivity and 93.2% specificity, compared to 25% sensitivity and 91.3% specificity with mammography. The next step is to compare the technology to magnetic resonance imaging and other screening methods, lead investigator Carrie Hruska noted in a Sept. 3 press release. MBI costs more than mammography, but one-fifth less than MRI, according to the study authors